Dallas Secures Position as One of Three Nationwide ARPA-H Innovation Hubs in Texas Triumph

by jess.house@todosdigital.com

Dallas, Texas, has been chosen as the site for one of the three regional hubs in the Advanced Research Projects Agency for Health’s (ARPA-H) new $2.5 billion health innovation initiative, ARPANET-H. This initiative aims to drive significant advancements in medical research and health outcomes across the United States.

The Texas consortium, which includes Dallas along with Houston, Austin, and San Antonio, successfully secured the placement of the Customer Experience hub at Dallas’ Pegasus Park, a center focusing on life sciences and social impact.

This designation represents a significant achievement for Texas and a notable development for Dallas, highlighting the state’s collaborative spirit and ambition to be at the forefront of health innovation. The ARPANET-H, inspired by the defense-focused DARPA, aims to catalyze breakthroughs in science and medicine, particularly in addressing diseases like cancer, Alzheimer’s, diabetes, among others, as part of President Biden’s Unity Agenda.

The Customer Experience hub in Dallas will work alongside two other ARPA-H hubs located in Cambridge, Massachusetts, and the Washington, D.C. region, focusing on investor engagement and stakeholder operations, respectively.

Together, these hubs will form a national network aimed at speeding up the development and dissemination of health innovations to the American public, with a special emphasis on accessibility and equity.

The selection of the Texas consortium is the culmination of a multi-city collaboration effort, highlighting the combined strengths and diversity of Texas’ healthcare and research capabilities. The initiative is seen as a major step towards making Dallas, and Texas more broadly, a central figure in the nation’s biotech and life science innovation landscape. It promises not only advancements in health care but also economic growth through job creation and increased investment in the region’s research infrastructure.

This announcement arrives just ahead of the 9th annual BioNTX iC3 Summit, underscoring the momentum building within the North Texas biotech and healthcare community. The summit aims to foster relationships that drive progress in the industry, mirroring the collaborative essence of the ARPA-H initiative. The Customer Experience hub’s focus on patient-centered solutions and its proactive approach to diversifying clinical trials underlines ARPA-H’s commitment to inclusive and impactful health innovation. As the project unfolds, the Dallas region looks forward to becoming a beacon of science and life sciences achievements, further strengthening its position within the national and global healthcare sectors.

Original article written by: Dallas Innovates

Dallas, Texas, has been chosen as the site for one of the three regional hubs in the Advanced Research Projects Agency for Health’s (ARPA-H) new $2.5 billion health innovation initiative, ARPANET-H. This initiative aims to drive significant advancements in medical research and health outcomes across the United States.

The Texas consortium, which includes Dallas along with Houston, Austin, and San Antonio, successfully secured the placement of the Customer Experience hub at Dallas’ Pegasus Park, a center focusing on life sciences and social impact.

This designation represents a significant achievement for Texas and a notable development for Dallas, highlighting the state’s collaborative spirit and ambition to be at the forefront of health innovation. The ARPANET-H, inspired by the defense-focused DARPA, aims to catalyze breakthroughs in science and medicine, particularly in addressing diseases like cancer, Alzheimer’s, diabetes, among others, as part of President Biden’s Unity Agenda.

The Customer Experience hub in Dallas will work alongside two other ARPA-H hubs located in Cambridge, Massachusetts, and the Washington, D.C. region, focusing on investor engagement and stakeholder operations, respectively. Together, these hubs will form a national network aimed at speeding up the development and dissemination of health innovations to the American public, with a special emphasis on accessibility and equity.

The selection of the Texas consortium is the culmination of a multi-city collaboration effort, highlighting the combined strengths and diversity of Texas’ healthcare and research capabilities. The initiative is seen as a major step towards making Dallas, and Texas more broadly, a central figure in the nation’s biotech and life science innovation landscape. It promises not only advancements in health care but also economic growth through job creation and increased investment in the region’s research infrastructure.

This announcement arrives just ahead of the 9th annual BioNTX iC3 Summit, underscoring the momentum building within the North Texas biotech and healthcare community. The summit aims to foster relationships that drive progress in the industry, mirroring the collaborative essence of the ARPA-H initiative. The Customer Experience hub’s focus on patient-centered solutions and its proactive approach to diversifying clinical trials underlines ARPA-H’s commitment to inclusive and impactful health innovation. As the project unfolds, the Dallas region looks forward to becoming a beacon of science and life sciences achievements, further strengthening its position within the national and global healthcare sectors.

 

Original article written by: Dallas Innovates

contact us

The Dallas Regional Chamber's economic development team works directly with companies, location consultants, and local and state allies to market the region and attract new and expanding corporations. We serve as a single point of contact for companies, site selection consultants, and corporate real estate executives examining the region.

Kelly Cloud

Vice President – Life Sciences
Dallas Regional Chamber
214.746.6749 
kcloud@dallaschamber.org

READY TO MEET?

community

bioNTX

BioNTX is the bioscience and healthcare innovation trade organization in North Texas, an affiliate of the Biotechnology Innovation Organization in Washington, DC. They are the bridge between businesses and job opportunities, providing direct cost savings services, networking events, and educational programming to the bioscience and healthcare innovation community in North Texas.